HOME › DRUGS › GADOFOSVESET TRISODIUM
ACTIVE SUBSTANCE / INN

GADOFOSVESET TRISODIUM

Brand name(s): Ablavar (previously Vasovist), ABLAVAR
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
NDA021711
Magnetic Resonance Angiography
ACTIVE SUBSTANCE
Gadofosveset Trisodium
REGULATORS
FDA · EMA
SPONSORS / MAH
LANTHEUS MEDCL, TMC Pharma Services Ltd.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ABLAVARNDA021711LANTHEUS MEDCLDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Ablavar (previously Vasovist)TMC Pharma Services Ltd.Withdrawn03/10/2005Magnetic Resonance Angiography

FULL INTELLIGENCE ON GADOFOSVESET TRISODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →